Status:
COMPLETED
Impact of Clomiphene Citrate Administration During the Early Luteal Phase on Endocrine Profile in IVF Cycles
Lead Sponsor:
Fundació Privada Eugin
Conditions:
Female Infertility
Eligibility:
FEMALE
18-35 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to evaluate the effect on LH levels of the 5-day CC administration during luteal phase in oocyte donors, to investigate whether the CC corrects the suppressed LH levels in...
Eligibility Criteria
Inclusion
- Oocyte donors
- 18-35 years old
- BMI 18-29 Kg/m2
- Normal basal hormonal levels
- No contraceptive pill
Exclusion
- Polycystic ovarian syndrome (PCOS)
- Previous participation in the study
Key Trial Info
Start Date :
June 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2013
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT01791751
Start Date
June 1 2012
End Date
February 1 2013
Last Update
February 15 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clínica EUGIN
Barcelona, Barcelona, Spain, 08029